deltatrials
Unknown PHASE2/PHASE3 NCT04756882

Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars

Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars (Randomized Clinical Trial )

Sponsor: Alexandria University

Conditions Hypertrophic Scarring
Interventions AbobotulinumtoxinA 500 UNT
Updated 4 times since 2021 Last updated: Feb 15, 2021 Started: Nov 18, 2020 Primary completion: May 18, 2021 Completion: Sep 1, 2021

A PHASE2/PHASE3 clinical study on Hypertrophic Scarring, this trial is ongoing. The trial is conducted by Alexandria University and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2/PHASE3

    Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Mar 2023 — Jul 2024 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Active Not Recruiting → Unknown Status

  4. Mar 2021 — Mar 2023 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alexandria University
Data source: Alexandria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Alexandria, Egypt